- Home
- NARI vs JANX Comparison
NARI vs JANX Comparison
Compare NARI & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- JANX
- Stock Information
- Founded
- NARI 2011
- JANX 2017
- Country
- NARI United States
- JANX United States
- Employees
- NARI N/A
- JANX N/A
- Industry
- NARI Medical/Dental Instruments
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- NARI Health Care
- JANX Health Care
- Exchange
- NARI Nasdaq
- JANX Nasdaq
- Market Cap
- NARI 4.7B
- JANX 3.0B
- IPO Year
- NARI 2020
- JANX 2021
- Fundamental
- Price
- NARI $79.85
- JANX $44.98
- Analyst Decision
- NARI Hold
- JANX Strong Buy
- Analyst Count
- NARI 12
- JANX 11
- Target Price
- NARI $69.22
- JANX $83.09
- AVG Volume (30 Days)
- NARI 4.8M
- JANX 1.1M
- Earning Date
- NARI 02-26-2025
- JANX 03-07-2025
- Dividend Yield
- NARI N/A
- JANX N/A
- EPS Growth
- NARI N/A
- JANX N/A
- EPS
- NARI N/A
- JANX N/A
- Revenue
- NARI $574,498,000.00
- JANX $13,049,000.00
- Revenue This Year
- NARI $24.62
- JANX $39.66
- Revenue Next Year
- NARI $18.00
- JANX N/A
- P/E Ratio
- NARI N/A
- JANX N/A
- Revenue Growth
- NARI 22.41
- JANX 54.12
- 52 Week Low
- NARI $36.73
- JANX $7.81
- 52 Week High
- NARI $79.89
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- NARI 80.06
- JANX 38.56
- Support Level
- NARI $79.60
- JANX $39.23
- Resistance Level
- NARI $79.76
- JANX $46.10
- Average True Range (ATR)
- NARI 0.18
- JANX 2.76
- MACD
- NARI -0.79
- JANX 0.20
- Stochastic Oscillator
- NARI 93.33
- JANX 28.02
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.